AtriCure, Inc. (ATRC) vs Beam Therapeutics Inc. (BEAM)

A side-by-side comparison of AtriCure, Inc. and Beam Therapeutics Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — ATRC vs BEAM

growth of $100 · dividends reinvested · last 7y
ATRC +42.7% (+5.2%/yr)BEAM +36.9% (+4.6%/yr)ATRC compounded faster over this window
200400600Start $100202120222023202420252026$143$137
ATRC BEAM

ATRC vs BEAM: by the numbers

  • •ATRC is the larger company ($2.80B vs $2.60B market cap).
  • •ATRC is profitable (1.85% net margin) while BEAM runs a net loss (-54.75%).
  • •BEAM grew revenue faster over the past five years (479.04% vs 18.57% CAGR).

Metrics side by side

Valuation

MetricATRCBEAM
P/E ratio259.22N/A
P/S ratio4.9116.64
P/B ratio5.422.43
EV / EBITDA77.74N/A
FCF yield1.83%N/A

Profitability

MetricATRCBEAM
Gross margin76.16%84.05%
Operating margin2.44%-274.57%
Net margin1.85%-54.75%
ROE2.04%-8.00%
ROIC2.04%-28.96%

Growth (annualized)

MetricATRCBEAM
Revenue CAGR (5Y)18.57%479.04%
Total return CAGR (5Y)-4.06%-21.41%

Frequently asked

Which has grown faster, ATRC or BEAM?
Over the past five years, BEAM grew revenue faster — ATRC at a 18.57% CAGR versus BEAM at 479.04%.
Is ATRC or BEAM more profitable?
ATRC runs the higher net margin — ATRC at 1.85% versus BEAM at -54.75%.
How have ATRC and BEAM total returns compared?
Over the past 5 years, ATRC delivered -4.06% and BEAM delivered -21.41% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.